OPRMO - Overview: Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy, Saliva

Test Catalog

Test Name

Test ID: OPRMO    
Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy, Saliva

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying individuals with a higher probability of successful treatment for alcoholism with naltrexone

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.


Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) 5'-Nuclease End-point Allelic Discrimination Analysis

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

OPRM1 Genotype, Naltrexone, Saliva

Aliases Lists additional common names for a test, as an aid in searching

Acamprosate Calcium (CAMPRAL)
CAMPRAL (Acamprosate Calcium)
Mu-Opioid Receptor (OPRM1)
Opioid mu Receptor
OPRM1 (mu-Opioid Receptor)